WASHINGTON — A federal choose Monday dominated towards a Justice Division antitrust problem to UnitedHealth Group Inc.’s
$13 billion acquisition of health-technology agency Change Healthcare Inc.
rejecting authorities claims that the deal would unlawfully suppress competitors and restrict innovation in health-insurance markets.
U.S. District Choose Carl Nichols dominated for the businesses in an opinion that he stored underneath seal for now as a result of he stated it “could comprise competitively delicate data.” The choose stated he would launch a redacted public model of the ruling within the coming days. In a one-page public order, he denied the Justice Division’s request to dam the businesses from finishing the deal.
The courtroom ruling represents an early blow to stepped-up antitrust enforcement by the Biden administration, which sued in February to dam the deal. The Justice Division didn’t instantly reply to a request for remark.
The choice is a triumph for UnitedHealth, which owns the biggest U.S. well being insurer and a healthcare operation that includes 1000’s of docs in addition to clinics, surgical procedure facilities and different belongings, together with a robust conglomeration of well being information.
In a press release, a UnitedHealth spokesman stated, “We’re happy with the choice and sit up for combining with Change Healthcare as shortly as attainable in order that collectively we are able to proceed our work to make the well being system work higher for everybody.”
Additionally widespread on WSJ.com: